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Differentially expressed genesMicroarrays allow researchers to examine the expression of thousands of genes simultaneously. However,
identiﬁcation of genes differentially expressed in microarray experiments is challenging. With an optimal test
statistic, we rank genes and estimate a threshold abovewhich genes are considered to be differentially expressed
genes (DE). This overcomes the embarrassing shortcoming of many statistical methods to determine the cut-off
values in ranking analysis. Experiments demonstrate that our method is a good performance and avoids the
problems with graphical examination and multiple hypotheses testing that affect alternative approaches.
Comparing to those well known methods, our method is more sensitive to data sets with small differentially
expressed values and not biased in favor of data sets based on certain distribution models.nce and Technology, Nanjing
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Microarrays allow researchers to examine the expression of thou-
sands of genes simultaneously. The primary goal of many microarray
experiments is to identify a group of DE between two or more con-
ditions. So far many statistical methods have been developed to
identify DE. The use of ranking analysis based on t-statistic is among
the ﬁrst practice [1–4].
Assume that we have a microarray data set on which NA samples
are from group A and NB samples are from group B and we wish to
identify which genes are DE. Many data analysis programs rank the
genes according to the absolute value of the t-statistic:
ti =
MAi−MBi
sp
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=NA + 1=NB
p ;
where, MAi
―
and M
―
Bi are mean expression measures of gene i from
group A and B, and sp is the total standard deviation. The primary
shortcoming of using t-statistics for ranking genes lies in that the true
distribution of gene expression variances might be neither completely
homogeneous nor completely heterogeneous. A more realistic
assumption might lie in between the two extreme cases, i.e., gene
variances arise from a mixture of the two components, one being a
point mass at a common variance, another being a continuous dis-
tribution. Under this mixture assumption, a differentially expressed
gene could have a large M
―
Ai−M
―
Bi or a large t-statistic, but not
necessarily both. Taking intersection of the rejection regions ﬂaggedby t-statistic will deﬁnitely lose power, but not necessarily lower the
false discovery rate (FDR) [5].
Subsequent to gene ranking on the basis of a suitable statistic, the
next step is to choose a cut-off value above which genes will be ﬂagged
as DE. Graphical approaches examine the ranking statistics in a normal
probability plot. The bulk of the genes should follow an approximate
straight-line on the plot. Geneswhose points deviatemarkedly from the
line are identiﬁed as DE. Unfortunately, the implicit assumptions of
normality and independence for the statistic betweengenes are unlikely
to be satisﬁed. The method tends in practice to over-estimate the
number of DE [4]. More formal approaches involvemultiple hypotheses
testing [6,7]. However, thismethod requires amoderate to largenumber
of samples in microarrays to give useful results. Also, estimation of the
false discovery rate relies on some assumptions about dependence
between the genes which are difﬁcult to verify in practice.
In this study, we propose a method based on marginal distribution
statistic (MDS) to select DE from a given microarray data set. In our
proposed method, we employ an optimal test statistic to rank genes.
Without the previously mentioned shortcomings of t-statistics, a gene
can be assigned to be DE according to its posterior probability based
on the new optimal test statistic. In order to avoid the problems of
graphical examination and independence assumptions of multiple
hypotheses testing, we estimate a threshold above which genes were
considered to be DE.
2. Marginal distribution statistic method
2.1. Marginal distribution model
Let M={X,Y}={x1, x2, L, xm, y} be the microarray over n tissue
samples. Where xi  Rn denote the i-th gene expression and y  {0, 1}
index the tissue type (normal vs. abnormal). We assume that data
Table 1
Summary of datasets used for experiments.
Dataset Diagnostic task Genes Samples Categories
Leukemia ALL and AML 7129 72 2
Lung Lung cancer and normal tissues 12,533 181 2
Prostate Prostate tumor and normal tissues 10,509 102 2
DLBCL Diffuse large B-cell lymphomas
(DLBCL) and follicular lymphomas
5462 77 2
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such as dye effect, chip effect, batch effect, etc. We are interested in a
four-cluster partition of genes: (I) genes unexpressed in all samples,
(II) genes expressed in abnormal tissue samples and unexpressed in
normal tissue samples, (III) genes unexpressed in abnormal tissue
samples and expressed in normal tissue samples, and (IV) gene
expressed in all tissue samples. Genes that belong to cluster II and III
will be considered to be DE.
The distribution of X is assumed to be a four-componentmixture of
multivariate normal distributions with marginal density
f x jθ1; θ2; θ3; θ4ð Þ = π1f1 x jθ1ð Þ + π2 f2 x jθ2ð Þ + π3 f3 x jθ3ð Þ + π4 f4 x jθ4ð Þ
ð1Þ
where πk is mixture proportions, and∑k=14 πk=1,θk is the parameter
set for the k-th component distribution, fk is the density functions
for multivariate normal distributions with themean μk and covariance
∑k, k=1, 2, 3, 4.
FromModel (1), a gene rankmethodcanbederivedwith its posterior
probability. Deﬁned x={x1, x2,⋯, xm}, the i-th gene is assigned to be DE
based on its posterior probability.
Pi xð Þ = Pr xi∈DE jxið Þ =
π2 f2 xi jθ2ð Þ + π3 f3 xi jθ3ð Þ
∑4k = 1πk fk xi jθkð Þ
ð2Þ
The estimates πk, θk and Pi(x) can be obtained via the expectation-
maximization (EM) algorithm [8]. Similar approach can be found in
reference [9,10].
2.2. Parameter estimation via the EM algorithm
The fully categorized data can be represented as {yi, i=1, ..., n}=
{(xiT, ziT)T, i=1, ..., n}, wheren is thenumberof genes, zi=(zi1, zi2, zi3, zi4)T
and zij=1 if xi is in the j-th gene cluster, zij=0otherwise. The likelihood
corresponding to (y1, L, yn) can then be written in the form
p X; Z jπ; μ∑ð Þ = ∏
m
i=1
∏
4
k=1
πzikk N xi jμk;∑kð Þ
zik ð3Þ
with natural logarithm
ln p X; Z jπ; μ ;∑ð Þ = ∑
m
i=1
∑
4
k=1
zik In πk + In N xi jμk;∑kð Þð Þ: ð4Þ
TheEMalgorithmgenerates, fromsome initial approximation,θk(0)=
{πk(0), μk(0),∑k(0)}, a sequence {θk(t)} of estimates. Each iteration consists
of the following steps:
1) E-step: Evaluate E zikð Þ jxi = πkN xi jμk ;∑kð Þ∑4j = 1πjN xi jμj ;∑jð Þ :
2) M-step: Find θ(t+1) to maximize E(zik)|xi:
Nk¼∑
m
i=1
zik¼∑
m
i=1
E zik jxið Þ ð5Þ
π t + 1ð Þ = Nk =m ð6Þ
μ t + 1ð Þk =
1
Nk
∑
m
i=1
E zik jxið Þxi ð7Þ
∑ t + 1ð Þk =
1
Nk
∑
m
i=1
E zik jxið Þ xi−μkð Þ xi−μkð ÞT ð8Þ
3) If the parameter estimates converge, then stop, otherwise, go to
Step 1.2.3. Assigning DE
The question of identifying DE according to a suitable statistic can
be restated as a problem in multiple hypothesis testing. In testing a
single hypothesis, the probability of a Type I error, i.e. of rejecting the
null hypothesis when it is true, is usually controlled at some desig-
nated level. When many hypotheses are tested and each test has a
speciﬁed Type I error probability, the chance of committing some
Type I errors increases, often sharply, with the number of hypotheses.
This may have serious consequences if the set of conclusions must be
evaluated as a whole. Numerous approaches to this issue and many
methods for resolving it have been proposed.
The traditional multiple testing procedure involves two steps:
ranking the hypotheses and then choosing a cut-off along the rankings.
Let's simplify this procedure.
Here we take error rates FDR [false discovery rate, the expected
percentage of non-differentially expressed genes (non-DE) among
claimed/detected DE] to assess the performance of our gene selection
method. Considered a ranked statistic Ti(x)=Pi(x), i=1, ..., m, let D be
thenumber of claimedDEandN the number of non-DE in claimedDE, c0
be the cut-off value greater than or equal towhich genes will be ﬂagged
as DE. Obviously, the cut-off value c0 satisﬁes TD (x)≥c0NTD+1 (x).
Deﬁne N/D=0 if D=0. We have FDR = E N =Dð Þ = E E ND jx
  
=
E 1D E N jxð Þ
 
, and E N jxð Þ = E ∑mi = 1I Ti xð Þ≥c0;xi∈non DEð Þ jx
 
=
∑Di = 1 1−Pi xð Þð Þ =∑Di = 1 1−Ti xð Þð Þ. Therefore, FDR = E 1D∑Di = 1

1−Ti xð Þð Þ.
Denote α as the controlled/expected FDR, let
c0 = TD xð Þ = Tmax i : 1
i
∑ij=1 1−Tj xð Þ
 
≤α
	 
 xð Þ ð9Þ
then c0 is the cut-off value greater than or equal to which genes will be
ﬂagged as DE guarantees that FDR≤α.
3. Methods to be compared
In this section, we describe three well knownmethods for detecting
differentially expressed genes with microarrays. These three methods
will be compared in experiments.
3.1. Multiple testing procedures (MTP) [11]
A classical procedure for testing a null hypothesis about themean of
a distributionor the equality of twomeans is the t-test.MTP implements
the step-up procedure[12] to control the FDR. Based on t-statistics, the
results of the procedure are summarized using adjusted p-values, which
reﬂect for each gene the overall experiment Type I error rate when
genes with a smaller p-value are declared differentially expressed.
3.2. Signiﬁcance analysis of microarrays (SAM)
This is a statistical technique for ﬁnding signiﬁcant genes in a set of
microarray experiments proposed by Tusher, Tibshirani, and Chu [4].
SAM uses repeated permutations of the data to determine if the ex-
pressions of any genes are signiﬁcantly related to a certain class of
Table 2
The accuracies (%) of classiﬁcation on leukemia data set.
Controlled FDR for gene selection Average
accuracies
0.01 0.02 0.03 0.04 0.05 0.06
MDS 98.32 97.52 96.57 96.33 96.31 95.42 96.75
SAM 98.39 97.26 96.61 96.35 95.65 95.02 96.74
EB 98.12 96.87 96.36 96.16 95.39 94.90 96.51
MTP 98.01 96.49 96.02 95.88 96.20 94.86 96.50
Table 3
The accuracies (%) of classiﬁcation on lung data set.
Controlled FDR for gene selection Average
accuracies
0.01 0.02 0.03 0.04 0.05 0.06
MDS 96.16 96.18 95.77 94.38 93.11 91.84 94.57
SAM 95.50 96.21 95.23 94.51 93.05 92.01 94.42
EB 95.72 95.82 95.15 94.02 92.73 90.51 93.99
MTP 93.49 93.34 92.62 91.88 90.19 89.84 91.89
Table 5
The accuracies (%) of classiﬁcation on DLBCL data set.
Controlled FDR for gene selection Average
accuracies
0.01 0.02 0.03 0.04 0.05 0.06
MDS 99.11 97.78 97.23 96.38 96.22 95.53 97.04
SAM 98.50 97.53 97.23 96.51 96.05 95.62 96.91
EB 99.02 96.88 96.51 94.96 96.13 95.63 96.52
MTP 98.06 96.64 97.03 95.83 95.18 94.86 96.19
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parameter delta, which is chosen by the user based on the FDR.
3.3. Empirical Bayes methods (EB) [13]
Newton et al. developed a method for detecting changes in gene
expression in a single two-channel cDNA slide using a hierarchical
gamma–gamma model [14]. Kendziorski et al. extended this to
replicate chips withmultiple conditions [13]. Inference is based on the
posterior odds of differential expression.
4. Experiment on real microarray
To assess the performance of our algorithm, we perform our
experiments on four well-known public data sets that provide binary
classiﬁcation problems: leukemia [15], lung cancer [16], prostate
cancer [17], and lymphoma (DLBCL) [18]. A summary about these data
sets is provided in Table 1.
The quality of a selected gene subset is assessed by its capability to
lead to an efﬁcient classiﬁer. Due to the good generalization ability,
support vector machine (SVM) is regarded as one of the best
algorithms for classifying microarray data. In this study, the standard
SVMwith Gaussian kernel is employed as the classiﬁer to estimate the
classifying accuracy based on the gene subset chosen by certain gene
selection method and the parameter Gamma is tuned to be 0.0002.
Most classiﬁcation tools for processing gene expression data use
either the threefold or the leave-one-out cross-validation to evaluate
the classifying accuracy of a microarray data set. Note that over-ﬁtting
is likely to occur for the leave-one-out approach. Therefore we
perform the threefold cross-validation ﬁve times to obtain 15
classifying accuracies, and their average is then calculated. The
experimental results are presented in Table 2–5.
Table 2–5 show the results of the classifying accuracies based on
selected DE sets from MDS and other three compared methods. We
select DE under the different controlled FDR. Among the four gene
selection method, the MDS, SAM and EB achieve better performanceTable 4
The accuracies (%) of classiﬁcation on prostate data set.
Controlled FDR for gene selection Average
accuracies
0.01 0.02 0.03 0.04 0.05 0.06
MDS 95.62 95.80 95.17 94.68 93.81 90.84 94.32
SAM 95.50 95.62 95.24 94.63 93.52 91.33 94.31
EB 94.72 95.72 95.25 94.32 92.75 90.21 93.83
MTP 93.40 94.23 92.31 91.63 91.19 89.64 92.07than MTP, and our method MDS gains the highest average accuracies
on all data sets. Experiments on real microarray suggest that MDS is a
good candidate for identifying differential expression; however, the
MDS can be performed more easily. Because we do not know which
genes are truly differentially expressed for these four microarray data
sets, in the next section, we test MDS via a simulation study.
5. Simulation
To further assess the MDS, we simulate a set of artiﬁcial data sets to
study theperformanceof ourMDSmethod.Wegenerate data as follows:
In scenario I, we simulate 40 samples with 10,000 genes in two
conditions based on MDS. We take model parameters similar to those
obtained in normalized prostate cancer dataset [17]. Simulated data
set is generated based on Model (1) with parameters π1=0.6,
μ11=μi2=−0.45, ∑11=∑12=0.6, π2=0.1, μ21=0.45, μ22=−0.35,
∑21=0.6, ∑22=0.4, π3=0.1, μ31=−0.4, μ32=0.3, ∑31=0.5,
∑32=0.55, π4=0.2, μ41=μ42=0.48, and ∑41=∑42=0.68. Where μkc
and Σkc are the mean and covariance of the k-th component in class c
tissue samples. Genes with relatively high (positive) means values are
considered to be “expressed gene,” others with relatively low
(negative) means values are considered to be “unexpressed gene.”
In scenario II, data sets are similar to scenario I, but the mean
values of differentially expressed genes between two conditions are
smaller than those in scenario I. The parameters are set to the same
except μ21=0.25, μ22=−0.15, μ13=−0.2, and μ32=0.15.
In scenario III, data sets are generated in gamma–gamma model
(GG) [14]. The GG model is deﬁned as Xij∣τi−1~Γ(α, τi−1), τi~Γ(ξ, 1/ν),
where Xij denotes the expression value of the i-th gene in sample j; ξ
and ν are the shape and scale parameters of the gamma distribution.
We have μ=E(Xij)=αν/(ξ−1), Σ=V ar(Xij)=αν2(α+ ξ−1)/
[(ξ−1)2(ξ−2)] [9]. Taking model parameters similar to those
obtained in Newton et al. [14], we simulate 40 samples with 10,000
genes in two conditions based on GG model. Similar to scenario I, II,
we set π1=0.6, π2=0.1, π3=0.1, and π4=0.2. Other parameters are
provided in Table 6.
Parameter estimates averaged over the 100 simulations on
scenario I are given in Table 7. As shown, the parameter estimates
are close to the true values, with little standard error.
Two error rates are proposed to assess the performance of gene
selection methods; they are FDR and SR (sensitivity rate, the
percentage of correctly identiﬁed differentially expressed genes).
Simulations are repeated 100 times and the averaged error rates are
used to assess the performance of the methodology. Since the FDR
estimates suggest that using an odds value greater than 1.0 as aTable 6
Parameters for simulated data set in scenario III.
Parameters in
GG (α, ξ, ν)
Estimated parameters
in MDS (μ,∑)
Corresponding
to scenario I
3.5, 10.5, 1.5 0.55, 0.13 μ11=μ12,∑11=∑12
12.5, 11.5, 1.5 1.79, 0.62 μ21,∑21
4.5, 9.5, 1.5 0.79, 0.24 μ22,∑22
4.0, 7.0, 1.0 0.67, 0.22 μ31,∑31
13.0, 11, 1.2 1.56, 0.48 μ32,∑32
13.5, 12.0, 1.5 1.84, 0.61 μ41=μ42,∑41=∑42
Table 7
Summary of parameter estimates for scenario I.
(k, c)
(1, *) (2, 1) (2, 2) (3, 1) (3, 2) (4, *)
μkc −0.45 0.45 −0.35 −0.4 0.3 0.48
μ^ck −0.45008 0.44903 −0.34728 −0.4001 0.3016 0.47013
μkc is the simulated mean value of k-th component in condition c, and μ^ck is the estimated
value of μkc on simulated data. Parameter estimates are averaged over 100 simulations,
where “*” can be replaced with number 1 or 2.
Table 8
Actual error rates of FDR and SR. The controlled FDR was set to be 0.05.
Scenario I Scenario II Scenario III
FDR SR FDR SR FDR SR
MDS 0.0490 0.892 0.0523 0.885 0.0510 0.860
EB 0.0492 0.876 0.0614 0.810 0.0510 0.862
SAM 0.0502 0.865 0.0602 0.819 0.0595 0.739
MTP 0.0615 0.603 0.0657 0.763 0.0621 0.666
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[13], we compare the actual error rates of FDR and SR at the cut-offs of
controlled FDR=0.05. For SAM method, FDR is determined by a
turning parameter delta. Experimental results are summarized in
Table 8.
For data sets in scenario I, MDS, EB and SAM perform as well.
However, for data sets in scenarios II, MDS performs better than the
others due to small differences in gene expression. For data sets in
scenario III (the GG-based model data set), the performance of MDS
and EB is equivalent and superior to SAM and MTP. The performance
of SAM is the general on GG-based model data set. Overall, the
proposed MDS performed best, and is sensitive to small differentially
expressed values like in scenarios II. More importantly, performance
of MDS is not biased in favor of data sets based on certain distribution
model.
6. Discussion
In this paper, we describe a new statistical method that is suitable
for analyzing microarray data to identify DE. With an optimal test
statistic, we rank genes and estimate a threshold above which genes
are considered to be DE. This overcomes the embarrassing shortcom-
ing of many statistical methods to determine the threshold in ranking
analysis. Experiments demonstrate that our method is a good
performance for identifying DE and avoids the problems with
graphical examination and multiple hypotheses testing that affect
alternative approaches. Comparing to those well known methods like
SAM and EB, our method is more sensitive to data sets with small
differentially expressed values and not biased in favor of data sets
based on certain distribution model.
Fraley and Raftery proposed a model-based clustering method
(MCLUST) which also assumes mixture of normal distributions with
general parameter structure [19,20]. The clustering process estimates
a model for the data that allows for overlapping clusters, producing a
probabilistic clustering that quantiﬁes the uncertainty of observations
belonging to components of the mixture. If used for microarray
analysis, gene clusters are ellipsoidal, centered at the means, and the
covariances determine their other geometric features. Since the
MCLUST doesn't take account for difference of expressed values of
genes between conditions, if the number of clusters is set to be 4, we
cannot get the same results as those obtained from the proposed
method.
We have compared our approach with three alternatives. There
are many other methods for detecting differentially expressed genes
with gene expression data. We choose these three because they are
either obvious baseline methods or widely used; they are also
representative of other methods.Acknowledgment
This work was supported in part by the Natural Science
Foundation of China (No. 60973094, No.61070121), the Postdoctoral
Science Foundation of China (No.20100481149) and the Natural
Science Foundation of the Jiangsu Higher Education Institutions of
China (No. 10KJB520006).References
[1] P.A. Mundra, J.C. Rajapakse, Gene and sample selection for cancer classiﬁcation
with support vectors based t-statistic, Neurocomputing 73 (13–15) (2010)
2353–2362.
[2] S.I. Meireles, et al., Differentially expressed genes in gastric tumors identiﬁed by
cDNA array, Cancer Lett. 190 (2) (2003) 199–211.
[3] Y.D. Tan, M. Fornage, Y.X. Fu, Ranking analysis of microarray data: a powerful
method for identifying differentially expressed genes, Genomics 88 (6) (2006)
846–854.
[4] V.G. Tusher, R. Tibshirani, G. Chu, Signiﬁcance analysis of microarrays applied to
the ionizing radiation response, Proc. Natl Acad. Sci. U.S.A. 98 (9) (2001)
5116–5121.
[5] S. Zhang, J. Cao, A close examination of double ﬁltering with fold change and t-test
in microarray analysis, BMC Bioinform. 10 (2009) 402.
[6] P.C. Roberts, Gene Expression Microarray Data Analysis Demystiﬁed, Vol. 14,
Elsevier, 2008, pp. 29–61.
[7] Y.D. Tan, H.M. Yan, Powers of multiple-testing procedures for identiﬁcation of
genes signiﬁcantly differentially expressed in microarray experiments, Acta
Genet. Sin. 33 (12) (2006) 1132–1140.
[8] A.P. Dempster, N.M. Laird, D.B. Rubin, Maximum likelihood from incomplete data
via the EM algorithm, J. R. Stat. Soc. B 39 (1) (1977) 1–38.
[9] W. Qiu, W. He, X. Wang, R. Lazarus, A marginal mixture model for selecting
differentially expressed genes across two types of tissue samples, Int. J.
Biostatistics 4 (1) (2008)8 Article 20.
[10] X. Zhou, et al., Novel Gaussianized vector representation for improved natural
scene categorization, Pattern Recognit. Lett. 31 (8) (2010) 702–708.
[11] S. Dudoit, J. Shaffer, J. Boldrick, Multiple hypothesis testing in microarray
experiments, Stat. Sci. 18 (1) (2003) 71–103.
[12] Y. Benjamini, D. Yekutieli, The control of the false discovery rate in multiple
testing under dependency, Ann. Stat. 29 (4) (2001) 1165–1188.
[13] C. Kendziorski, M. Newton, H. Lan, M. Gould, On parametric empirical Bayes
methods for comparingmultiple groups using replicated gene expression proﬁles,
Stat. Med. 22 (24) (2003) 3899–3914.
[14] M. Newton, C. Kendziorski, C. Richmond, F. Blattner, K. Tsui, On differential
variability of expression ratios: improving statistical inference about gene
expression changes from microarray data, J. Comput. Biol. 8 (1) (2001) 37–52.
[15] T.R. Golub, et al., Molecular classiﬁcation of cancer: class discovery and class
prediction by gene expression monitoring, Science 286 (1999) 531–537.
[16] G.J. Gordon, et al., Translation of microarray data into clinically relevant cancer
diagnostic tests using gene expression ratios in lung cancer and mesothelioma,
Cancer Res. 62 (2002) 4963–4967.
[17] D. Singh, et al., Gene expression correlates of clinical prostate cancer behavior,
Cancer Cell 1 (2) (2002) 203–209.
[18] A. Alizadeh, et al., Distinct types of diffuse large b-cell lymphoma identiﬁed by
gene expression proﬁling, Nature 403 (6769) (2000) 503–511.
[19] C. Fraley, A.E. Raftery, Mclust: software for model-based cluster analysis, J. Classi-
ﬁcation 16 (1999) 297–306.
[20] C. Fraley, A.E. Raftery, Model-based methods of classiﬁcation: using the mclust
software in chemometrics, J. Stat. Software 18 (6) (2007) 1–13.
